Belma, Baby Girl -.

HRN: 26 10 02  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/23/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
10/23/2024
10/30/2024
IV
75mg
Q24H
PCAP C
Waiting Final Action 

Indication:  ProphylaxisEmpiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: